UNIGE document Scientific Article - Review
previous document  unige:142183  next document
add to browser collection
Title

Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review

Authors
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
Published in The Journal of International Medical Research. 2019, vol. 47, no. 1, p. 31-43
Abstract Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN (R). The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN (R) in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.
Keywords Diabetic macular oedemaSteroid implantFluocinolone acetonideILUVIENDiabetesAnti-VEGF agentsDiabetic retinopathyIntravitreal injections
Identifiers
PMID: 30556449
Full text
Article (Published version) (489 Kb) - public document Free access
Erratum (105 Kb) - public document Free access
Other version: http://journals.sagepub.com/doi/10.1177/0300060518816884
Structures
Research group Ophtalmologie expérimentale (925)
Citation
(ISO format)
MASSA, Horace et al. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. In: The Journal of International Medical Research, 2019, vol. 47, n° 1, p. 31-43. doi: 10.1177/0300060518816884 https://archive-ouverte.unige.ch/unige:142183

110 hits

41 downloads

Update

Deposited on : 2020-09-29

Export document
Format :
Citation style :